Cargando…
Systemic sclerosis medications and risk of scleroderma renal crisis
BACKGROUND: Scleroderma Renal Crisis (SRC) is associated with significant morbidity and mortality. While prednisone is strongly associated with SRC, there are no previous large cohort studies that have evaluated ace inhibitor (ACEi) calcium channel blocker (CCB), angiotensin receptor blocker (ARB),...
Autores principales: | Gordon, S. M., Hughes, J. B., Nee, R., Stitt, R. S., Bailey, W. T., Little, D. J., Edison, J. D., Olson, S. W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6659266/ https://www.ncbi.nlm.nih.gov/pubmed/31345158 http://dx.doi.org/10.1186/s12882-019-1467-y |
Ejemplares similares
-
Renal Disease and Systemic Sclerosis: an Update on Scleroderma Renal Crisis
por: Cole, Alice, et al.
Publicado: (2022) -
Autoantibodies are present before the clinical diagnosis of systemic sclerosis
por: Burbelo, Peter D., et al.
Publicado: (2019) -
Scleroderma Renal Crisis in a Systemic Sclerosis With Anti-PM/Scl Antibodies
por: Jacquier, Marine, et al.
Publicado: (2019) -
A 45-Year-Old Man with Scleroderma Renal Crisis Associated with a History of Systemic Sclerosis Sine Scleroderma
por: Hansrivijit, Panupong, et al.
Publicado: (2020) -
Acute kidney injury in a patient with systemic sclerosis: Looking beyond scleroderma renal crisis
por: Goswami, R. P., et al.
Publicado: (2015)